Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren F Stevenson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bioanalysis|April 19, 2019
Perspectives on gender parity in bioanalysis: an interview with Lauren StevensonLauren F Stevenson
Bioanalysis|May 15, 2026
From tiers to truth - a biomarker-based framework for clinically relevant immunogenicity assessmentLauren F Stevenson
Bioanalysis|May 27, 2026
Immunogenicity assays are biomarker assays: is the 3-tiered paradigm fit-for-purpose? An illustrative case studyLauren F Stevenson
Bioanalysis|January 16, 2014
Parallelism: considerations for the development, validation and implementation of PK and biomarker ligand-binding assaysLauren F Stevenson, Shobha Purushothama
Bioanalysis|May 5, 2026
Rethinking immunogenicity: an integrated approach reveals the PK/PD impact of pre-existing and drug-sustaining ADADevangi Mehta, William Wargin, Stephanie Wallace-Teliz, et al.
Bioanalysis|December 13, 2019
Well-developed ligand-binding assays demonstrate robust performance using singlet analysisDouglas Donaldson, Shobha Purushothama, Eric David, et al.
The EMBO Journal|February 10, 2007
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2Lauren F Stevenson, Alison Sparks, Nerea Allende-Vega, et al.
The Journal of Biological Chemistry|July 29, 2004
Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivoMark K Saville, Alison Sparks, Dimitris P Xirodimas, et al.
The AAPS Journal|January 8, 2014
Large molecule run acceptance: Recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization TeamMarian Kelley, Christopher Beaver, Lauren F Stevenson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bioanalysis|April 19, 2019
Perspectives on gender parity in bioanalysis: an interview with Lauren StevensonLauren F Stevenson
Bioanalysis|May 15, 2026
From tiers to truth - a biomarker-based framework for clinically relevant immunogenicity assessmentLauren F Stevenson
Bioanalysis|May 27, 2026
Immunogenicity assays are biomarker assays: is the 3-tiered paradigm fit-for-purpose? An illustrative case studyLauren F Stevenson
Bioanalysis|January 16, 2014
Parallelism: considerations for the development, validation and implementation of PK and biomarker ligand-binding assaysLauren F Stevenson, Shobha Purushothama
Bioanalysis|May 5, 2026
Rethinking immunogenicity: an integrated approach reveals the PK/PD impact of pre-existing and drug-sustaining ADADevangi Mehta, William Wargin, Stephanie Wallace-Teliz, et al.
Bioanalysis|December 13, 2019
Well-developed ligand-binding assays demonstrate robust performance using singlet analysisDouglas Donaldson, Shobha Purushothama, Eric David, et al.
The EMBO Journal|February 10, 2007
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2Lauren F Stevenson, Alison Sparks, Nerea Allende-Vega, et al.
The Journal of Biological Chemistry|July 29, 2004
Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivoMark K Saville, Alison Sparks, Dimitris P Xirodimas, et al.
The AAPS Journal|January 8, 2014
Large molecule run acceptance: Recommendation for best practices and harmonization from the Global Bioanalysis Consortium Harmonization TeamMarian Kelley, Christopher Beaver, Lauren F Stevenson, et al.
Pageof 1